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nents of the technique must not be compromised by
skills and training of the individual performing either
part of the procedure. Also, in the absence of sufficient
length of ideal conduit for a distal bypass, balloon
angioplasty may remove a discrete lesion distally, per-
mitting longer-term patency of an otherwise compro-
mised graft. The determination of combining or per-
forming the procedures sequentially will be deter-
mined by local circumstances.
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D4.8
Infrainguinal Disease-Surgical Treatment
The main guiding principles behind surgical recon-
struction are to bypass into the best available outflow
vessel possible regardless of the anatomic level and to
construct the bypass graft with autogenous vein.
Further explanation and exceptions to these principles
are discussed in the following sections. The issue of
aboue-knec femoropoplitcal bypass grafting has been
addressed earlier (see B 4.4, Surgery for Intermittent
Claudication, p 597). When a bypass graft is con-
structed to an outflow artery below the knee, autoge-
nous tissue is accepted as the preferred conduit.
04.8.1
Inflow
Before reconstruction of infrainguinal PAD, the sur-
geon must ensure adequate inflow to the groin level or
site of proximal anastomosis (see also
Recommendation 88, p 5178). The common femoral
artery or an inflow graft is the usually accepted origin
of a femoral distal bypass graft. A number of authors
have reviewed experience with more distal take-off of
bypass grafts (profunda, SFA, popliteal) and have
found that in appropriately chosen individuals there
is no compromise to the bypass.t-e For example, a
stenosis of 20% or more in the native superficial
Eur J Vase Endovasc Surg Vol 19 Supplement A, June 2000
femoral artery proximal to a graft origin has been cor-
related with eventual graft failure.' Because athero-
sclerosis is a generalised and in many cases progres-
sive disease, distal origin bypass grafts should be
undertaken only when inflow to that level is uncom-
promised. This issue is of some importance when
alternative (and presumably shorter) segments of vein
must be used for bypass grafts.
Recommendation 89: Inflow artery for femorodistal
bypass
Any artery, regardless of level (ie, not only the com-
mon femoral artery), may serve as an inflow artery
for a distal bypass provided that flow to that artery
and the origin of the graft is uncompromised.
o 4.8.2
Outflow (Run-off) Arteries
The guiding principle here is to choose the distal out-
flow artery that allows the best perfusion of the foot.
Any distal artery, including the pedal arteries, may
serve as a suitable outflow tract with acceptable
expected patency rates.t- The results of
femora-below-knee popliteal grafting are similar to
femoral distal bypass grafting. The choice of the site of
the distal anastomosis should be based on the quality
of the distal artery and its runoff and not the length of
the bypass. The main exceptions to this relate to the
lack of adequate length of suitable vein.
04.8.3
Distal Bypass Grafts
The same principles as outlined in the previous sec-
tion on femoral-popliteal lesions apply to more distal
bypass grafts. The increased length of the required
conduit introduces some special problems in the
absence of long saphenous vein, and these arc dis-
cussed in the following sections. There should be no
effort to compromise the length of bypass just to have
the distal anastomosis in the popliteal artery rather
than a distal artery. The best distal artery should be
selected, because this will give the best long-term
patency rates.
Recommendation 90: Femorofemoral distal bypass
outflow vessel
In a femoral crural bypass, the least diseased distal
artery with the best continuous run-off to the
ankle/foot should be used for outflow regardless of
location, provided there is adequate length of suit-
able vein.
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D 4.8.4
Isolated Popliteal Artery Segment
When there is no direct communication between the
popliteal artery and the tibial vessels, this "isolated
popliteal artery" may be used as an outflow tract,"
This situation, which usually arises when there is a
shortage of vein, is an exception to the previously dis-
cussed guiding principle. The indication for such an
operation would be CLI and the absence of sufficient
length of suitable vein for bypass into a more appro-
priate vessel. Five-year patency rates for bypasses to
an isolated popliteal segment were reported as PTFE,
55%; saphenous vein, 74%; and limb salvage rates as
PTFE, 56%; and saphenous vein, 79%.7 Suggested
requirements for a successful bypass to the blind
popliteal artery were a segment of artery of at least 7
ern and at least one major collateral vessel draining the
segment. Large perigeniculate collateral arteries have
been used successfully as outflow vessels in some
patients."
Recommendation 91: Bypass to an isolated
popliteal artery
Bypass to an isolated popliteal artery should be
considered as an alternative when no crural or
pedal bypass is possible or realistic (eg, because of
shortage of vein). An adequate segment of popliteal
artery with collateral outflow to the foot is required
to ensure ongoing patency.
D 4.8.5
Choice of Conduit
(See B 4.4.2, Surgical Procedures, p 597) For infra-
geniculate reconstruction, there is general agreement
that the conduit should be constructed of autogenous
vein. Good results have been achieved by a variety of
techniques. However, the preferred reconstruction is
with ipsilateral long saphenous vein (either in situ or
reversed). If this is not available, the preferred alterna-
tives in order of preference are single-segment venous
bypass (contralateral greater saphenous vein, arm
vein, etc.) followed by spliced veins from any source.
Finally, composite or prosthetic grafts with adjunct
procedures (vein cuff, distal AV fistula) may be con-
sidered, provided expected patency is sufficiently
high to justify patient risk. Basic science and clinical
investigations continue into the development of alter-
native bypass conduits when autogenous vein is not
available. These include arterial and venous homo-
grafts, but additional study is required to determine
their efficacy. Results from a variety of conduits are
shown in Table 47, showing diminishing results as less
favorable bypass grafts are used. Direct comparison
studies (in addition to those already shown) are
shown in Table 48.
For bypasses below the knee, autogenous tissue is
far superior to any other conduit. A randomised con-
trol trial comparing PTFE with autogenous vein found
significantly improved results in bypass grafts distal
to the knee when vein was used in the reconstruction."
This is confirmed in a meta-analysis by Hunink (see
Table 49, p 5189).10
Initial good results with improved techniques for in
situ bypass grafts led to claims of better long-term
patency rates. However, when this technique was
compared with reversed saphenous vein graft, a num-
ber of randornised trials failed to support this state-
ment.11•12 On the contrary, at 5 years the primary paten-
cy rate for in situ bypasses was 46.2%, compared with
68.8% for reversed bypasses (p < O.05).J2 Such ran-
domised comparisons also reflect problems in com-
paring the two approaches, such as greater (learning
curve) experience needed for in situ bypass and
greater need for secondary procedures to deal with
residual arteriovenous fistulas (graft stenoses being
equivalent). In general, the techniques are considered
equivalent, with tapering vein creating a diameter
mismatch in infrageniculate bypass being the solitary
advantage to in situ bypass. Although some claim that
reversed vein has the advantage that it can be moved
to the required location, antegrade use of dislocated
vein after valve disruption holds the same advantage
and can be used to overcome diameter mismatch.
However, the secondary patency rate was comparable
in the two groups (71.6% in situ vs 79.4% reversed).
This demonstrates the need for meticulous follow-up
of vein bypass grafts.
The quality of the vein can affect the outcome. A
saphenous vein is optimal if the vessel wall is thin, the
endothelium intact, and the diameter at least 4 mm.
The length and estimate of the diameter of available
veins is frequently assessed preoperatively with
duplex scanning, in the order of choice (ipsilateral
greater saphenous, contralateral greater saphenous,
lesser saphenous, and arm veins). This practice and
the abandonment of unnecessary disqualification of
patients with coronary disease (ie, "saving" veins for
the heart) has greatly increased vein utilisation. It has
been found that even those with previous partial
greater saphenous removal for vein stripping, or har-
vest for CABG or other bypasses, commonly have suf-
ficient vein left in the same leg for an infrainguinal
bypass.'> Those veins that require modification for dis-
ease at the time of the original procedure are more apt
to require further modification to maintain patency,'!
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Arm vein is easily accessible and can provide excellent
results over the long term." The configuration of the
arm vein may be a total segment of basilic or cephalic
vein, which is either reversed or undergoes valve
destruction. An alternative is to use a basilic-cephalic
loop with one segment requiring valve lysls.»
Composite vein grafts composed entirely of vein
but constructed from a number of different segments
or sources have proved adequate conduits. Sources of
vein may include remnants of long saphenous vein,
short saphenous vein, and arm vein.'? Some studies
report results as good as single-segment long saphe-
nous vein bypass grafts,IS and others suggest that,
although good, the results are not comparable.t? The
results of spliced vein grafts to the popliteal and distal
vessels at 4 years are: primary, 45%, and secondary,
61%. These results are improved if at least some of the
graft is in situ long saphenous vein. 20 Although direct
comparison trials have not been performed, this
approach would seem better than other alternatives,
that is, the other adjunctive procedures discussed in
this section. However, the revision rate to maintain
patency is approximately 20%, and a careful program
of surveillance is required to achieve optimum results.
Superficial femoral vein has been suggested as a
suitable conduit with very acceptable patency rates.
The removal of the superficial femoral vein may be
complicated by limb oedema, but this generally settles
with time and elastic support." Size discrepancy may
pose a problem in some patients. However, patency
rates equivalent to those for long saphenous vein
bypass grafts have been reportedP.23
Recommendation 92: Femoral below-knee popliteal
and distal bypass
An adequate long saphenous vein is the optimal
conduit in femoral below-knee popliteal and distal
bypass. In its absence, other good-quality vein
should be used.
D4.8.6
Other Conduits
Available conduits for femoral popliteal bypass grafts
include PTFE,·HUV, and Dacron. Results are varied,
and reports tend to be selected case studies. A ran-
domised trial comparing PTFE and Dacron at the
popliteal level gave similar results.2U 5 Although some
randornised trials have reported superiority of HUV
over PTFE or Dacron with respect to patency, this has
not been a consistent finding26•2?,2S and late degenera-
tive changes in HUV with aneurysm formation offset
any potential patency advantage.e? The major determi-
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nant of graft patency is the type of graft used, and vein
is superior to any prosthesis.w"
Composite grafts (prosthetic vein)
When insufficient autologous vein is available for dis-
tal bypass grafting, there is a question of whether
there is an advantage to constructing some of the
bypass graft with vein (composite bypass graft) rather
than use prosthesis entirely. Most studies show a dif-
ference or at least a trend toward improved patency
with composite grafts32,33 but no randomised trial data
are available comparing all prosthetic (with or with-
out vein cuff) with composite grafts. Studies are diffi-
cult to compare because there is usually minimal
information regarding the percentage of the graft that
is composed of vein.
D 4.8.7
Role of the Profundaplasty Alone
The role for profundaplasty is well accepted as an
adjunct to inflow procedures to maintain graft paten-
cy and reduce the need for subsequent or simultane-
ous distal reconstruction (see also Management of
Coexisting Infra inguinal Occlusive Disease, p 5177).
The role of isolated profundaplasty is more controver-
sial. Clinical success with such a procedure has been
achieved in 49% of patients at 3 years.>' A review of
the literature has suggested that requirements for suc-
cess include (1) excellent inflow, (2) a greater than 50%
stenosis in the proximal third of the profunda, and (3)
the presence of excellent collateral flow to the tibial
vessels in continuity with a foot with no tissue 10ss.35
In an attempt to evaluate collateral flow distal to the
profundaplasty as a predictor of success, a high seg-
mental limb pressure gradient across the knee (AK-BK
pressure/AK pressure> 0.5) has been found to predict
clinical failure.v There are no other successful objec-
tive predictors of success of isolated profundaplasty.
D 4.8.8
Assessing Run-off
In a large, nonrandomised, retrospective study,
Darling et al? reviewed bypass grafts to the peroneal
(n = 888) and dorsalis pedis artery (n = 291). No dif-
ference was found in patency or limb salvage at 1 and
5 years between the two groups (5-year secondary
patency peroneal, 76%; dorsalis pedis, 68%). These
findings are confirmed by other authors.3S,39 Even in
the presence of pedal gangrene, the peroneal artery
may be an appropriate outflow tract.'?
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When performing a bypass for CLI, the outflow ves-
sel must be widely patent, with adequate run-off, and
this principle must not be compromised to shorten the
length of the bypass. At least one study has shown
that long-term patency may be predicted by the ade-
quacy of the pedal arch." Three-year pedal artery graft
patencies were compared with more proximal crural
bypass grafts and yielded comparable results (82%
pedal vs 79% tibial, secondary patency) as well as
yielding comparable limb salvage rates (92% pedal vs
87% tibial) .«
A variety of methods exist for the intraoperative
assessment of graft flow and run-off
resistance/impedance. Variable results have been
reported from a variety of sophisticated methods of
assessment.43,44,45 Although these methods have been
shown to predict patency, they have not gained wide-
spread acceptance because they require completion of
the bypass graft before predicting success. The
SVS/ISCVS reporting standards for evaluating run-off
resistance, taking into account a number of factors, has
been modified and validated by Peterkin et aP6based
on angiography and multiple linear regression analy-
sis. However, it tends to be less predictive of vein than
prosthetic graft patency, the former faring much better
in the face of poor run-off.
04.8.9
Adjuvant Procedures to Improve Patency
At times there is insufficient available autogenous tis-
sue with which to construct a bypass graft. The results
of reinforced PTFE to arteries distal to the popliteal
have been reported as 45% and 25% at 2 and 5 years,
respectively, but are generally lower. Patency rates
were reduced if the bypass was a secondary procedure
or if the pedal arch was not intact. Many other sur-
geons are unable to match these results when per-
forming prosthetic distal bypass grafts. The following
sections review adjuvant procedures to improve
patency of the disadvantaged (especially prosthetic)
bypass graft.
Arteriovenous fist lila
This procedure has been advocated by some when dis-
tal bypass graft is constructed with PTFE. The princi-
ple is to decrease vascular resistance and thereby
increase flow in the graft while not creating a hemo-
dynamically significant steal phenomenon. The two
most common types are (1) the "common ostia ,"
where the artery and vein are sutured in such a fash-
ion that an arteriovenous fistula is created at the site of
the distal anastomosis" and (2) a separate remote arte-
riovenous fistula constructed distal to the artery-pros-
thes is anastornosis.w'?
There is a lack of good data to support the use of
arteriovenous fistula on a routine basis, Anecdotal
reports of graft patency of 71% and limb salvage of
83% have been published.s' In a prospective, ran-
domised study, Hamsho et al51 compared graft paten-
cy and limb salvage after femoro-infrapopliteal
bypass using ePTFE with and without addition of
adjuvant arteriovenous fistula . The differences in
cumulative rates of primary patency and limb salvage
at 1 year after operation were not statistically signifi-
cant (55.2% and 54.1% for patients with arteriovenous
fistula compared with 53.4% and 43.2%, respectively,
for the control groupl.v Follow-up with duplex scan-
ning suggests that ongoing venous patency is impor-
tant to the continued function of the graft.52
Arteriovenous fistula, if used at all, should be
reserved for tibial or peroneal bypasses in those situa-
tions with poor run-off or a "disadvantaged graft."
Vei/l interposition/cuff
Among the adjunct techniques, creating a venous
patch or cuff at the distal anastomosis of a prosthetic
graft has been described by a number of authors.
Millerv has described a "silo" configuration, whereas
Taylor inserts a patch over just the distal toe of the
anastomosis. Tyrrell and Wolfe>t have shaped the cuff
to improve its configuration (the so-called St Mary's
boot) . In 1995, Raptis and Millerv reported the results
of primary femoropopliteal PTFE grafting with and
without an interposition vein cuff. There was no dif-
ference in the patency rates between cuffed and direct
suture for above-knee popliteal bypass grafts (69%
and 68% for cuffed and direct suture, respectively, at
36 months),« There was, however, an appreciable dif-
ference for the below-knee bypass grafts (57% vs 29%,
respectively, at 36 months).» These figures were later
confirmed by Stonebridge et al36 in a randornised trial.
The results supported the use of an interposition vein
cuff when PTFE grafts were anastomosed to the
popliteal artery below the knee, with 2-year patency
rat es for cuffed and uncuffed grafts of 52% and 29%,
respectively (p = 0.03). A more recent randomised
study from Belgium did not support the initial posi-
tive results with the use of vein interposition cuffs.v A
comparison of a current series with historical controls
suggests that venous cuffs increase patency for pros-
thetic grafts carried to crural vessels.v Further studies
are needed to establish the role of adjuvant procedures
in femoropopliteal or femoral crural prosthetic bypass
grafts (see Critical Issue 35).
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Critical Issue 35: Adjunctive procedures with
prosthetic infrainguinal bypass grafts
There is a need to determine whether an adjuvant
procedure (such as arteriovenous fistula or vein
cuff) significantly improves patency when it is nec-
essary to use a prosthetic conduit for a
femoropopliteal or femoral crural bypass.
D 4.8.10
Results of Infrainguinal Bypass Grafts
In large studies, the major determinant of long-term
graft patency is the type of graft material used as well
as the continued use of tobacco." One review of a per-
sonal series of 2,274 bypass grafts reports primary
patency of in situ grafts as: 1 year, 84%; 5 years, 72%;
10 years, 55%; with no difference in patency detected
when stratified for inflow artery, outflow artery, and
length of bypass'" (see Tables 47 and 48). Average
results are shown in Figure 25 on page 5199.
Table 47: Selected results of infrainguinal bypass with various conduits
Operative Primary patency (%) Secondary Patency (%)
CLI Mortality
Patients (%) (%) 1 yr 2 yrs 3 yrs 5 yrs 1 yr 2 yrs 3 yrs 5 yrs Comments
RevCTsed greater saphenous teiu
Rutherford 100
et al, 198827
Taylor et aI, 1990 22
Gentile et al, 199618 268
Hall et al, 198561 52
ill situ
Belkin et al, 1996 386
Feinberg et al, 199032 57
Alexander et al, 1996 119
Londrey et al, 199133 61
LS Yother
Belkin et al, 199662 168
Londrey et al, 199)33 93
Londrey et al, 199417 i69
Myers et al, 1993'" 537
Arm Veill
Chalmers et al, 199465 42
Harward et al, 199266 43
Harris et al, 198467 70
Myers et al, 1993'" 49
Spliced Veill
Harris et aI, 1986"" 54
Chang et al, 199520 114
Londrey et al, 199417 88
Taylor et aI, 198769 140
Taylor et aI, 198709 189
Anklefdistal.al! rein
Panayiotopoulos et al, 199670109
Davidson & Callis, 199371 75
Quinones- 46
Baldrich et al, 1993n
Shah et al, 199659 487
Compositepartial prosthesis
Fichelle et al, 199573 145
McCarthy et al, 19927' 67
DeMasi & Snyder, 199573 85
Feinberg et al, 199032 108
Londrey et al, 199133 45
Alexander et al, 199663 35
Distalprosthesis
Schweiger et al, 1993u 211
75
100
2
23
100 2
97
92 1
92 4
100 1
92 4
88 2
43
95 0
93 0
83 0
43
100 6
95 4.4
88 2
81 1.5
69 1.5
100 7
100 6
100 0
91 3.5
100 3.3
100 0
99
97
92 4
92
100 3.3
75
98
85
82
80
67
85
63
58
72
95
89
89
72
83
72
35
63
64
46
79
64
30
35
37
63
83
68
81
49
72
69
83
84
27
68
72
41
48
22
74
68
72
66
59
73
68
70
35
26
23
83
76
78
74
80
56
93
89
55
45
74
68
67
85
53
64
-Q
50
50
ipsilateral
80
74 74
75 Nonreversed
61 59 Reversed vein
59 52 Single length,
any vein
Reversed vein
64% infrapopliteal
64 34% infrapopliteal
56% infrapopliteal
78% tibial
77 Part in situ
39 29
Other vein
Partial ipsilateral
vein
45 Crural/pedal
82 70 All vein to foot
Distal ankle
77
40 Sequential 100%
infra popliteal
47 85% infrapopliteal
44 28
25 100% infrapop-
liteal
Londrey et al, 199)33 33 92 4 7 63 38 26 7
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Table 48:Selected results of comparative studies of infrainguinal bypass grafts
8189
Operative
Patients CLI (%) mortality (%) 1 yr
Primary patency (%)
3 yrs 4 yrs 5 yrs Comments
>90% lnfrapopliteal comparisons-s-ail studies
Veill type
Taylor et at 199QNl 285 80 1 89
231 80 1 84
Gentile et at 199618 268 2 98
58 2 85
133 1 83
Distalanastomosis
Donaldson et al, 199F· 440 68 87
299 100 2 83
240 91
200 82
GrafttyJ'e
Veith et 'II, 1986· 106 86 6
98 88 4
Cranley & Hafner, 198277 40 100 2 59
13 100 33
Edwards & Mulherin, 19807ll 57 88 82
29 93 21
15 93 7
Rutherford et al, 198827 50 98 88
22 100 75
14 71 25
21 95 7
Hall et al, 198561 52 23 85
27 48 63
47 62 54
84
71
83
82
75
84
81
86
81
88
63
17
7
68
49
34
49
12
80
68
74
82
72
83
81
86
78
GSV
other vein
ipsilateral GSV
contralateral GSV
other vein
all grafts
CLI only
popliteal
anastomosis
distal anastomosis
any vein
PTFE
any vein
HUV
any vein
PTFE
HUV
insituGSV
reversed GSV
PTFE
HUV
RSV
Composite
PTFE
D 4.8.11
Results of Femoropopliteal Bypass Grafts
A meta-analysis performed by Hunink and col-
leagues'? involved strict entry criteria, which permit-
ted pooling of data with reanalysis of stratified cate-
gories of patients. Papers published between 1983 and
1995 were included if they were original reports not
duplicating previous data, included the numeric data
for the Kaplan-Meier analysis, defined patency as
haemodynamic improvement, and reported the distri-
bution of covariates. The reanalysis of 2,060 patients
surgically treated allowed for the assessment of 1,572
patients with CLI. Overall results of femoral distal
bypass reports for CLI are depicted in Table 49, show-
ing a clear advantage for vein bypass grafts.1O
A review of reports of the results of infrainguinal
revascularisation procedures published between 1981
and 1990 was performed by Dalman and Taylor (Table
50).79 Although limited information is given about
inclusion criteria, analysis techniques, or the raw data,
they have confirmed the superiority of autogenous tis-
sue in infrainguinal bypass. The previous comments
comparing in situ and reversed vein should be con-
sidered before accepting the superiority of one over
the other (see 0 4.8.5, Choice of Conduit, p SI85).
Table 49:Summary of results of a meta-analysis of femoropopliteal bypass grafts (critical limb ischaemia only)IO
Conduit
Vein (any level)
Above-knee PTFE
Below-knee PTFE
Table 50: Summary: below-knee femoropoplileal grafts'/9
Conduit
Reverse saphenous vein
In situ vein bypass
Human Umbilical Vein
Polytetrafluoroethylene (PTFE)
Primary patency at 5 years
66%
47%
33%
Primary patency at 4 years
77%
68%
60%
40%
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